These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1356327)

  • 41. The treatment of myocardial infarction.
    Timmis GC; Terrien E
    J Interv Cardiol; 1995 Dec; 8(6 Suppl):730-51. PubMed ID: 10159764
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term therapy after an acute myocardial infarct].
    Lengfelder W; Senges J
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1201-4. PubMed ID: 1353722
    [No Abstract]   [Full Text] [Related]  

  • 44. What data support our current thrombolytic management of patients with acute myocardial infarction?
    Sobolski JC
    Prog Cardiovasc Dis; 1992; 34(6):367-78. PubMed ID: 1349756
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacologic therapy for acute myocardial infarction. Which agent, how much, how soon, how long?
    Rapaport E
    Postgrad Med; 1997 Nov; 102(5):143-5, 148-50, 152-4 passim. PubMed ID: 9385337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical therapy of acute myocardial infarction: Part II. The role of adjunctive medical therapy.
    Jafri SM; Borzak S
    J Intensive Care Med; 1995; 10(3):109-16. PubMed ID: 10155176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacotherapy following myocardial infarction].
    Spinarová L; Spinar J; Vítovec J
    Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals.
    Ergin A; Abaci A; Sakalli A; Eryol NK; Oguzhan A; Unal S; Cetin S
    Int J Cardiol; 1999 Mar; 68(3):309-16. PubMed ID: 10213283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis.
    Becker RC; Gore JM
    Am J Cardiol; 1991 Jan; 67(3):25A-31A. PubMed ID: 1671315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic therapies after myocardial infarction.
    Rapaport E; Gheorghiade M
    Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
    Yusuf S
    Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of severity of "risk region" on therapeutic intervention of myocardial infarction size.
    Mukherjee D
    Indian J Pathol Microbiol; 1992 Jul; 35(3):241-6. PubMed ID: 1344159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjunctive therapy in the management of patients with acute myocardial infarction.
    Reeder GS
    Mayo Clin Proc; 1995 May; 70(5):464-8. PubMed ID: 7731256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions that potentially limit myocardial infarct size: overview of clinical trials.
    Yusuf S
    Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical therapy after acute myocardial infarction.
    Jafri SM; Gheorghiade M; Mahdyoon H; Goldstein S
    Curr Probl Cardiol; 1991 Sep; 16(9):585-649. PubMed ID: 1684544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Adjuvant therapy in acute myocardial infarction: evidence based recommendations].
    Avezum A; Cavalcanti AB; Sousa AG; Farsky PS; Knobel M
    Rev Assoc Med Bras (1992); 2000; 46(4):363-8. PubMed ID: 11175574
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta-blockers, angiotensin-converting enzyme inhibitors, and calcium antagonists in treatment of elderly patients with acute myocardial infarction.
    Aronow WS
    Coron Artery Dis; 2000 Jun; 11(4):331-8. PubMed ID: 10860176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
    Yusuf S; Wittes J; Friedman L
    JAMA; 1988 Oct; 260(14):2088-93. PubMed ID: 2901501
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment at discharge after myocardial infarction in 2,102 patients. The PRIMA study. Prise en charge de l'Infarctus du Myocarde Aigu.
    Excoffier S; De Gevigney G; Ecochard R; Rabilloud M; Cao D; Cheneau E; Milon H; Delahaye F
    Acta Cardiol; 2001 Feb; 56(1):17-26. PubMed ID: 11315120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
    Tereshchenko SN; Aleksandriia LG; Moiseev VS
    Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.